Obesity drugs that demonstrate benefits in cardiovascular disease, chronic kidney disease, sleep apnea, MASH, and metabolic syndrome may command stronger payer support and longer treatment duration
Dietary Supplementation with Glycine Enhances Intestinal Mucosal Integrity and Ameliorates Inflammation in C57BL/6J Mice with High-Fat Diet-Induced Obesity Kheirandish, V., et al
Similarly, semaglutide was originally approved for diabetes under the brand name Ozempic in 2017, and then later approved for obesity (under the name Wegovy) in 2021
In models of cerebral ischemia (stroke), it has protected brain tissue from damage and improved functional recovery by reducing inflammation and apoptosis in the ischemic penumbra (Raghavan and Shah 2015)
This refreshing drink based on natural mineral water contains 1,000 mg of L-Carnitine
2024;73(Supplement_1):117-OR